Literature DB >> 32269444

AL Amyloidosis in a Patient with IgD Myeloma.

Hicham Rafik1, Kawtar Hassani1, Taoufiq Aatif1, Driss El Kabbaj1, Samira E Idrissi2, Zohra Ouzzif2.   

Abstract

Entities:  

Year:  2019        PMID： 32269444      PMCID： PMC7132855          DOI： 10.4103/ijn.IJN_78_19

Source DB:  PubMed          Journal:  Indian J Nephrol        ISSN： 0971-4065


× No keyword cloud information.
  11 in total

1.  IgD-kappa myeloma: an unusual case.

Authors:  Amy M Tharp; Ralph D Woodruff; Zak K Shihabi
Journal:  Ann Clin Lab Sci       Date:  2003       Impact factor: 1.256

2.  Immunoglobulin D amyloidosis: a distinct entity.

Authors:  Morie A Gertz; Francis K Buadi; Suzanne R Hayman; David Dingli; Angela Dispenzieri; Philip R Greipp; Shaji K Kumar; Martha Q Lacy; John A Lust; Nelson Leung; S Vincent Rajkumar; Stephen J Russell; Steven R Zeldenrust; Joseph R Mikhael; Vivek Roy; Robert A Kyle
Journal:  Blood       Date:  2011-11-07       Impact factor: 22.113

3.  Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients.

Authors:  M K Kim; C Suh; D H Lee; C-K Min; S J Kim; K Kim; J H Moon; S S Yoon; G-W Lee; H J Kang; S-H Kim; C W Choi; H S Eom; J-Y Kwak; H J Kim; Y-C Mun; S-M Bang; K Lee; H J Shin; J H Lee
Journal:  Ann Oncol       Date:  2010-08-02       Impact factor: 32.976

4.  IgD monoclonal gammopathy with long-term follow-up.

Authors:  J Bladé; R A Kyle
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

5.  Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins.

Authors:  G C White; R J Jacobson; R A Binder; R P Linke; G G Glenner
Journal:  Blood       Date:  1975-11       Impact factor: 22.113

6.  Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements.

Authors:  Shaji Kumar; Angela Dispenzieri; Martha Q Lacy; Suzanne R Hayman; Francis K Buadi; Colin Colby; Kristina Laumann; Steve R Zeldenrust; Nelson Leung; David Dingli; Philip R Greipp; John A Lust; Stephen J Russell; Robert A Kyle; S Vincent Rajkumar; Morie A Gertz
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

7.  IgD multiple myeloma. Review of 133 cases.

Authors:  Z Jancelewicz; K Takatsuki; S Sugai; W Pruzanski
Journal:  Arch Intern Med       Date:  1975-01

8.  Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Authors:  Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Philip R Greipp; Thomas E Witzig; John A Lust; S Vincent Rajkumar; Rafael Fonseca; Steven R Zeldenrust; Christopher G A McGregor; Allan S Jaffe
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

9.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

Review 10.  Unusual myelomas: a review of IgD and IgE variants.

Authors:  Shivlal Pandey; Robert A Kyle
Journal:  Oncology (Williston Park)       Date:  2013-08       Impact factor: 2.990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.